Aqu Alu

12PUBLICATIONS
31CO-AUTHORS
Biological adaptationInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 30, 2026
Aromaticity at spike position 456 affects functional immunogenicity of SARS-CoV-2 Omicron variant receptor-binding domain.

|Jul 26, 2026
Mucosal immunity and vaccine development.

|Nov 30, 2025
Integrative analysis of non-small cell lung cancer identifies Jumonji domain-containing 6/ETS homologous factor axis as a target to overcome radioresistance.

Manni Wang, Li Xu, Aqu Alu

|Aug 06, 2025
Immunosenescence: signaling pathways, diseases and therapeutic targets.

Yichu Fu, Binhan Wang, Aqu Alu

|Feb 25, 2025
A recombinant protein vaccine induces protective immunity against SARS-CoV-2 JN.1 and XBB-lineage subvariants.

Jingyun Yang, Weiqi Hong, Huashan Shi

|Nov 20, 2024
Intranasal delivery of a subunit protein vaccine provides protective immunity against JN.1 and XBB-lineage variants.

Hong Lei, Weiqi Hong, Jingyun Yang

Pageof 2

Frequent Collaborators

8 joint publications

Xiawei Wei

6 joint publications

Guangwen Lu

6 joint publications

Weiqi Hong

5 joint publications

Wei Wang